Editor's Note Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health told the Kaiser Health News on September 1 that a COVID-19 vaccine could be available earlier than expected if clinical trial results are overwhelmingly positive. An independent Data and…

Read More

Editor's Note The National Academies of Sciences, Engineering, and Medicine, on September 1, released draft guidelines to help policymakers plan for equitable allocation of a COVID-19 vaccine. The committee that drafted the guidelines was formed at the request of the National Institutes of Health and Centers for Disease Control and…

Read More

Editor's Note This study by researchers from Iceland finds that antibodies against COVID-19 remained stable 4 months after diagnosis. The researchers measured antibodies in serum samples from 30,576 people in Iceland, using six assays (including two pan-immunoglobulin (pan-Ig) assays). They then tested 2,102 samples collected from 1,237 people up to…

Read More

Editor's Note This study, led by economists from Washington University in St Louis, finds that the ideal COVID-19 vaccine policy should emphasize age more than work-exposure risk for vaccination priority. To provide a best-practice scenario to supplement a vaccine distribution strategy, the researchers tracked eight age groups in more than…

Read More

Editor's Note In an interview with the Financial Times, Food & Drug Administration (FDA) Commissioner Stephen Hahn, MD, on August 30, said the FDA could fast-track approval of a COVID-19 vaccine before late-stage clinical trials are complete if regulators believe the benefits of doing so outweigh the risks. Dr Hahn…

Read More

Editor's Note The University Hospitals Cleveland Medical Center (UH) announced August 24 that it will participate as a study site for the Phase 2/3 global trial of the Pfizer/BioNTech investigational COVID-19 vaccine. UH is one of approximately 120 clinical investigational sites around the world that will collectively enroll up to…

Read More

Editor's Note A Gallup poll of US adults conducted from July 20 to August 2 finds that 35% of those surveyed would not be interested in receiving a COVID-19 vaccine when one is approved by the Food & Drug Administration. The survey also finds that 41% of non-white Americans would…

Read More

Editor's Note Johnson & Johnson (J&J) announced July 30 that it has started its human safety trials to assess its COVID-19 vaccine, after reporting on details of its animal study. A single dose of the vaccine completely protected all six animals from lung disease and five of six from infection,…

Read More

Editor's Note The Department of Health and Human Services (HHS) and Department of Defense on July 22 announced an agreement with Pfizer to produce and deliver 100 million doses of its COVID-19 vaccine in the US, following manufacture and approval. Pfizer will deliver the doses, once the vaccine receives emergency…

Read More

Editor's Note This study by Cleveland Clinic researchers identifies genetic factors that may influence susceptibility to COVID-19, which could guide personalized treatment. The researchers investigated genetic susceptibility to COVID-19 by examining DNA polymorphisms (variations in DNA sequences) in the ACE2 and TMPRSS2 genes that produce the enzymes that enable the…

Read More